Market Recap — August 11, 2026
Market Snapshot
Markets traded in a cautious, mixed tone on Tuesday as traders positioned ahead of Wednesday's CPI release while digesting elevated geopolitical tension in the Middle East. No closing index data was provided for the session, but the day's newsflow pointed to energy-driven inflation concerns competing with optimism around AI infrastructure developments.
Key Drivers
- Oil Prices Rise on Strait of Hormuz Uncertainty — U.S. crude climbed above $83 per barrel, gaining as much as 3% intraday, after Iran signaled the Strait of Hormuz would remain restricted until conditions are met. President Trump's demand for Iranian reparations added to supply concerns, keeping energy names in focus and reinforcing inflation anxiety ahead of tomorrow's CPI print.
- CPI Anticipation Dominates Pre-Market Sentiment — With the July consumer price index due Wednesday, traders adopted a wait-and-see posture. Expectations point to a modest increase, which could influence Fed rate expectations. The positioning dynamic likely contributed to muted activity as market participants avoided large directional bets before the data release.
- AI Infrastructure Deals Signal Continued Investment Cycle — Multiple headlines underscored ongoing capital flows into AI. Intel upsized its stock offering to $20 billion at $95 per share citing accelerating AI demand, while Riot Platforms announced a $9 billion, 20-year compute deal with Anthropic. Nvidia also released its Nemotron 3.5 Lightning open-source model and received analyst praise for new financial partnerships that diversify its customer base. These developments supported sentiment in the technology sector.
- Gold Holds Above $4,400 Amid Geopolitical Risk — Precious metals maintained their bid with gold remaining above $4,400, driven by the same Iran-related tensions lifting crude. The safe-haven demand reflects ongoing uncertainty around potential escalation in the Gulf region.
- Healthcare Names Draw Attention on Mixed Catalysts — Cardinal Health received price target upgrades following strong profit guidance, while Eli Lilly's Foundayo weight-loss pill gained its first European approval in the U.K., extending its competitive push against Novo Nordisk. These company-specific developments provided positive momentum for healthcare positioning.
Bottom Line
Tuesday's session was defined by pre-CPI caution layered over persistent geopolitical risk from the Iran situation. Energy and safe-haven assets caught a bid while technology benefited from continued AI investment announcements. Traders should watch Wednesday's inflation report closely—a benign print could reinforce expectations for Fed accommodation, while an upside surprise may pressure rate-sensitive sectors. The Strait of Hormuz situation remains a wildcard for energy prices and broader risk sentiment.
OrbStats Strategy Pulse
Light trading day across our strategies, with only three triggering setups. MGC ORB 30s Breakout and MNQ ORB 9:30-9:45 EMA50-Filtered both posted clean 1-0 wins, bringing in $100 each—nice to see the MNQ strategy snap its brief losing streak. On the flip side, FDXS 30sec Opening and Micro DAX ORB both extended their losing runs to two days, each dropping $120. The broader trend we're watching: several of our core strategies are cooling off versus their 90-day baselines. SIL New York Opening shows the widest gap, with its 30-day average trailing its prior baseline by over $42 per day—though it's still sitting on a 2-day win streak, so no panic there. Similarly, MGC and MNQ EMA50-Filtered are both underperforming their historical averages, something worth monitoring if the softness persists. Meanwhile, MNQ MidRange is quietly on a 4-day winning streak without trading today—we'll see if it can extend that run when it next triggers.